Sector Update: Healthcare Higher Pre-Market; ImmunoGen Spikes 7% on Earnings


Shutterstock photo

Healthcare stocks:

JNJ: flat

PFE: flat

ABT: flat

MRK: flat

AMGN: flat

Healthcare shares are flat in pre-market trade.

In healthcare stocks news, ImmunoGen, Inc. ( IMGN ) is up 7.3% in pre-market after it earlier reported a Q1 loss of $0.13 per share, ex one-time items, compared with the prior-year period's $0.30 loss per share. Revenues were $17.2 million, up from million in the same quarter last year.

Revenues for the quarter include $13.2 million in license and milestone fees, compared to $0.9 million in the comparable quarter a year ago. Analysts polled by Capital IQ were expecting a loss of $0.22 per share on revenues of $12.55 million.

And, BioMarin Pharmaceutical Inc. ( BMRN ) in yesterday's after-hours reported a Q3 GAAP loss of $0.38 per diluted share, compared to GAAP net loss of $0.04 per share for the comparable quarter of 2012. Analysts polled by Capital IQ estimated a GAAP and non-GAAP loss of $0.30 per share.

Revenues of $134.3 fell short of CIQ consensus for $139.8 million, but were higher than revenues of $126.3 million in the prior year period.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2014 All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing , Commodities
More Headlines for: BMRN , IMGN

More from MT Newswires


MT Newswires

MT Newswires

Market News, Commodities
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by